| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 05/01/2013 | EP2585442A1 Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives |
| 05/01/2013 | EP2585441A1 Process for olmesartan medoxomil |
| 05/01/2013 | CN103080095A Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| 05/01/2013 | CN103073454A Synthetic method for beta-aminocarbonyl compound, beta-mercapto ketone and beta-alkoxy ketone |
| 05/01/2013 | CN103073372A Method for synthesizing amine compound catalyzed by functionalized ionic liquid |
| 05/01/2013 | CN101821246B Tetrazole-substituted aryl amide derivatives and uses thereof |
| 05/01/2013 | CN101321750B Multimeric magnetic resonance contrast agents |
| 04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 04/24/2013 | CN102070546B Preparation method of 1-(2-ethoxyl)-5-mercapto tetrazole |
| 04/24/2013 | CN101305006B Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 04/23/2013 | CA2529257C Methods and compositions for treating amyloid-related diseases |
| 04/18/2013 | WO2013056163A1 Beta-lactamase inhibitors |
| 04/18/2013 | WO2013056079A1 High affinity beta lactamase inhibitors |
| 04/18/2013 | US20130096168 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 04/18/2013 | US20130096127 Substituted aminopropionic derivatives as neprilysin inhibitors |
| 04/17/2013 | CN103052630A Highly crystalline valsartan |
| 04/17/2013 | CN103044345A Synthetic method of 1-(2-ethoxyl)-5-sulfydryl-1H-tetrazole |
| 04/11/2013 | WO2013050512A1 Method for functionalizing a solid substrate, other than a substrate made of gold, via specific chemical compounds |
| 04/10/2013 | EP2576522A1 Zn (ii) based colorimetric sensor and process for the preparation thereof |
| 04/10/2013 | EP2576521A1 Gadobutrol preparation in a one-pot process by means of dmf acetal and n-methylimidazole |
| 04/10/2013 | CN103030633A Process and intermediate compounds useful in the preparation of statins |
| 04/09/2013 | US8415368 Acid secretion inhibitor |
| 04/09/2013 | CA2588881C Potentiators of glutamate receptors |
| 04/04/2013 | WO2013045431A1 Sulfonamide compounds and their use in the modulation retinoid - related orphan receptor |
| 04/03/2013 | CN103012302A Production process of clofentezine |
| 04/03/2013 | CN103012301A Valsartan methyl ester alkali metal salt and preparation method thereof |
| 04/03/2013 | CN103012300A Novel method for preparing valsartan |
| 04/03/2013 | CN103012299A HMX preparation method based on DMSO/H20 (Dimethyl Sulfoxide/H2O) binary system |
| 04/02/2013 | US8410154 Tetrazole compounds for reducing uric acid |
| 04/02/2013 | US8410141 Insecticidal arylpyrrolines |
| 04/02/2013 | CA2537292C 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/28/2013 | WO2011006935A3 Tetrazole derivatives |
| 03/27/2013 | CN103003252A Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives |
| 03/27/2013 | CN102993114A Method for producing 1H-tetrazole-5-acetic acid |
| 03/27/2013 | CN101817795B Improved method for synthesizing valsartan |
| 03/27/2013 | CN101448785B Novel dipeptidyl peptidase iv inhibitors and processes for preparation and pharmaceutical compositions thereof containing the same |
| 03/26/2013 | US8404730 3-substituted propanamine compounds |
| 03/26/2013 | US8404728 Small-molecule botulinum toxin inhibitors |
| 03/26/2013 | CA2474424C Salts of valsartan |
| 03/21/2013 | WO2013039187A1 Guanidinobenzoic acid compound |
| 03/21/2013 | US20130071328 Propynoic Acid Carbamoyl Methyl-Amides and Pharmaceutical Compositions and Methods Based Thereon |
| 03/21/2013 | CA2848561A1 Guanidinobenzoic acid compound |
| 03/20/2013 | EP2570407A1 Tetrazole-substituted arylamide derivatives and their use as P2x3 and/or P2x2/3 purinergic receptor antagonists |
| 03/20/2013 | CN102093302B Valsartan compound and new manufacturing method thereof |
| 03/19/2013 | CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/14/2013 | US20130066252 Method for diagnosis for multiple sclerosis involving anti1-receptor antibody |
| 03/14/2013 | US20130066068 Photo-responsive liquid crystalline compound and its applications |
| 03/13/2013 | EP2566853A1 Tetrazolones as inhibitors of fatty acid synthase |
| 03/13/2013 | CN102971303A Zn (Il) based colorimetric sensor and process for the preparation thereof |
| 03/12/2013 | US8394967 Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives |
| 03/12/2013 | US8394844 EP4 agonist |
| 03/12/2013 | US8394799 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
| 03/07/2013 | WO2013031776A1 Battery electrolyte and method for producing same, and battery comprising electrolyte |
| 03/06/2013 | CN102952033A Novel compound, composing method thereof and therapeutic use therefor |
| 03/06/2013 | CN101560218B Organometallic complex of nonlinear optical and ferroelectric material, synthesis and application thereof |
| 03/05/2013 | US8389500 Fused heterocyclic compounds as ion channel modulators |
| 02/28/2013 | WO2013026768A1 Energetic active composition comprising a dihydroxylammonium salt or diammonium salt of a bistetrazolediol |
| 02/28/2013 | US20130052130 Branched Discreet PEG Constructs |
| 02/28/2013 | CA2839188A1 Energetic active composition comprising a dihydroxylammonium salt or diammonium salt of a bistetrazolediol |
| 02/27/2013 | EP2562169A1 Tetrazolium compound for detecting microorganisms, reagent for detecting microorganisms and method for detecting microorganisms |
| 02/27/2013 | EP2560933A2 Alternative to tetrazene |
| 02/27/2013 | CN102947277A Photoresponsive liquid crystal compound and use thereof |
| 02/27/2013 | CN102942532A Preparation method of 1,4,7,10-tetraazadodecane |
| 02/26/2013 | US8383660 Dibenzyl amine compounds and derivatives |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/19/2013 | US8377978 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 02/14/2013 | WO2012148148A9 Novel zinc azide complex and a process for preparing tetrazole derivatives using the same |
| 02/14/2013 | US20130041001 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| 02/13/2013 | EP2556059A1 Improved process for preparing valsartan |
| 02/13/2013 | CN102933562A Gadobutrol preparation in a one-pot process by means of dmf acetal and n-methylimidazole |
| 02/13/2013 | CN102924397A Dual-component micromolecular organic gel |
| 02/13/2013 | CN102924396A Method for crystal transformation from alpha-HMX to beta-HMX |
| 02/12/2013 | US8372985 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process of making reaction products from cyclic α, β-unsaturated ketone substrates and nitroso substrates |
| 02/07/2013 | WO2013017559A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides |
| 02/07/2013 | US20130034494 Radiolabeled prostate specific membrane antigen inhibitors |
| 02/06/2013 | EP2552886A1 Cytokine inhibitors |
| 02/06/2013 | CN102911129A Method for preparing substituted tetrazole compound |
| 02/06/2013 | CN102911128A Synthetic method of valsartan |
| 02/05/2013 | US8367711 Angiotensin II receptor antagonists |
| 01/31/2013 | US20130030022 Compounds Which Selectively Modulate The CB2 Receptor |
| 01/30/2013 | CN102906075A Process for the preparation of 5-substituted 1-alkyltetrazoles |
| 01/30/2013 | CN102898392A N-acetoxyphenyl-3-[tri-tert-butoxy formyl-tetraazacyclododecane] intermediate and preparation method thereof |
| 01/30/2013 | CN102898391A 10-(carboxymethyl-amino)-ethyl-3-[tri-tert-butoxy formyl-tetraazacyclododecane] and preparation method thereof |
| 01/30/2013 | CN102250031B High-purity valsartan compound |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/24/2013 | WO2013010488A1 An intermediate of statin drugs and preparation thereof |
| 01/24/2013 | CA2841385A1 An intermediate of statin drugs and preparation thereof |
| 01/23/2013 | CN102887890A Synthesis method of candesartan cilexetil |
| 01/23/2013 | CN102887870A Octogen for detonating tube |
| 01/23/2013 | CN102887836A L-phenylglycine derivative and application thereof |
| 01/17/2013 | WO2012129452A3 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon |
| 01/16/2013 | EP2545040A1 Process for the preparation of 5-substituted 1-alkyltetrazoles |
| 01/16/2013 | CN102875485A Method for controlling impurity VLSI-M in valsartan |
| 01/16/2013 | CN102875484A Preparation method of 1-ethoxyl-5-sulfydryl-1H-tetrazolium |
| 01/09/2013 | EP2542539A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 01/09/2013 | EP2542089A1 Nuclear transport modulatiors and uses thereof |
| 01/09/2013 | CN102863398A Synthetic method for sartan drug intermediate and application of intermediate |
| 01/09/2013 | CN101648918B Intermediate compound of candesartan cilexetil and synthesis method thereof |